Shanghai ZJ Bio-Tech Co

Shanghai ZJ Bio-Tech Co ROA

The Return on Assets (ROA) of Shanghai ZJ Bio-Tech Co (688317.SS) as of Oct 31, 2026 is -0.91 %. In the previous year, Return on Assets (ROA) was -3.36 % — a change of -72.90% (higher).

ROA

-0.91 %

YoY

-72.90%

Last updated:

In 2025, Shanghai ZJ Bio-Tech Co's return on assets (ROA) was -0.91 %, a -72.90% increase from the -3.36 % ROA in the previous year.

The Shanghai ZJ Bio-Tech Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
10.75 CNY
Jan 1, 2019
8.03 CNY
Jan 1, 2020
49.59 CNY
Jan 1, 2021
17.83 CNY
Jan 1, 2022
16.03 CNY
Jan 1, 2023
-3.36 CNY
Jan 1, 2024
-3.36 CNY
Jan 1, 2025
-0.91 CNY
The Shanghai ZJ Bio-Tech Co ROA history
YEARROAYoY
-0.91 %-72.90%
-3.36 %+0.12%
-3.36 %-120.96%
16.03 %-10.10%
17.83 %-64.05%
49.59 %+517.81%
8.03 %-25.35%
10.75 %+7.67%
9.99 %+7.88%
9.26 %+12.21%
8.25 %-52.93%
17.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai ZJ Bio-Tech Co Stock analysis

What does Shanghai ZJ Bio-Tech Co do? Shanghai ZJ Bio-Tech Co., Ltd. generates revenue through the research, development, production, and sale of molecular diagnostic reagents and instruments. The company's primary products are nucleic acid detection kits and molecular diagnostic instruments, which are sold to customers in sectors including emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The firm focuses its business activities within the domestic market, targeting institutions and organizations requiring diagnostic solutions for public health and clinical applications. The company's business model centers on providing diagnostic reagents and equipment for critical applications such as emergency public health safety and medical clinical diagnosis. Its products are designed to meet the needs of domestic customers in healthcare, public safety, and food safety sectors, with a strong emphasis on molecular diagnostics. Shanghai ZJ Bio-Tech leverages its domestic market presence to serve institutions requiring reliable diagnostic tools for health and safety monitoring. Shanghai ZJ Bio-Tech Co., Ltd. operates with a domestic market focus, selling its molecular diagnostic instruments and reagents to entities involved in public health, clinical diagnosis, and food safety. The firm's revenue streams are derived from the sale of nucleic acid detection kits and molecular diagnostic instruments, which are essential for applications in emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. Shanghai ZJ Bio-Tech Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding Shanghai ZJ Bio-Tech Co's Return on Assets (ROA)

Shanghai ZJ Bio-Tech Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Shanghai ZJ Bio-Tech Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Shanghai ZJ Bio-Tech Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Shanghai ZJ Bio-Tech Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Shanghai ZJ Bio-Tech Co stock

Return on Assets (ROA) of Shanghai ZJ Bio-Tech Co is -0.91 % in 2025.

Return on Assets (ROA) of Shanghai ZJ Bio-Tech Co changed from -3.36 % to -0.91 %, representing a -72.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Shanghai ZJ Bio-Tech Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Shanghai ZJ Bio-Tech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Shanghai ZJ Bio-Tech Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Shanghai ZJ Bio-Tech Co